These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 7857031)

  • 1. [Contrast products in magnetic resonance imaging].
    Bonnemain B
    Ann Pharm Fr; 1994; 52(5):229-39. PubMed ID: 7857031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contrast agents: magnetic resonance.
    Burtea C; Laurent S; Vander Elst L; Muller RN
    Handb Exp Pharmacol; 2008; (185 Pt 1):135-65. PubMed ID: 18626802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hepatic and hepatocarcinoma magnetic resonance: comparison of the results obtained with paramagnetic (gadolinium) and superparamagnetic (iron oxide particles) contrast media].
    Castoldi MC; Fauda V; Scaramuzza D; Vergnaghi D
    Radiol Med; 2000 Sep; 100(3):160-7. PubMed ID: 11148882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Myocardial microcirculation in humans--new approaches using MRI].
    Wacker CM; Bauer WR
    Herz; 2003 Mar; 28(2):74-81. PubMed ID: 12669220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pushing the sensitivity envelope of lanthanide-based magnetic resonance imaging (MRI) contrast agents for molecular imaging applications.
    Aime S; Castelli DD; Crich SG; Gianolio E; Terreno E
    Acc Chem Res; 2009 Jul; 42(7):822-31. PubMed ID: 19534516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Basic principles of magnetic resonance contrast agents.
    Kirsch JE
    Top Magn Reson Imaging; 1991 Mar; 3(2):1-18. PubMed ID: 2025431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemistry of paramagnetic and diamagnetic contrast agents for Magnetic Resonance Imaging and Spectroscopy pH responsive contrast agents.
    Pérez-Mayoral E; Negri V; Soler-Padrós J; Cerdán S; Ballesteros P
    Eur J Radiol; 2008 Sep; 67(3):453-8. PubMed ID: 18455343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo biochemical 7.0 Tesla magnetic resonance: preliminary results of dGEMRIC, zonal T2, and T2* mapping of articular cartilage.
    Welsch GH; Mamisch TC; Hughes T; Zilkens C; Quirbach S; Scheffler K; Kraff O; Schweitzer ME; Szomolanyi P; Trattnig S
    Invest Radiol; 2008 Sep; 43(9):619-26. PubMed ID: 18708855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrast agents in magnetic resonance imaging of the liver: present and future.
    Clément O; Siauve N; Lewin M; de Kerviler E; Cuénod CA; Frija G
    Biomed Pharmacother; 1998; 52(2):51-8. PubMed ID: 9755795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced liver MR: contrast agents and imaging strategy.
    Runge VM; Kirsch JE; Wells JW; Awh MH; Bittner DF; Woolfolk CE
    Crit Rev Diagn Imaging; 1993; 34(1-2):1-30. PubMed ID: 8216813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic resonance imaging of thymic epithelial tumors.
    Kushihashi T; Fujisawa H; Munechika H
    Crit Rev Diagn Imaging; 1996 Aug; 37(3):191-259. PubMed ID: 8872410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spin-lock MRI with amplitude- and phase-modulated adiabatic waveforms: an MR simulation study.
    Taheri S; Sood R
    Magn Reson Imaging; 2006 Jan; 24(1):51-9. PubMed ID: 16410178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual contrast enhanced magnetic resonance imaging of the liver with superparamagnetic iron oxide followed by gadolinium for lesion detection and characterization.
    Kubaska S; Sahani DV; Saini S; Hahn PF; Halpern E
    Clin Radiol; 2001 May; 56(5):410-5. PubMed ID: 11384141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A central nervous system lupus showing peculiar findings on cranial magnetic resonance imaging (MRI)].
    Takahashi T; Kokubun Y; Okuhata Y; Sawada S; Mizutani T
    Rinsho Shinkeigaku; 2003 Jul; 43(7):409-16. PubMed ID: 14582367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro evaluation of alternative oral contrast agents for MRI of the gastrointestinal tract.
    Babos M; Schwarcz A; Randhawa MS; Marton B; Kardos L; Palkó A
    Eur J Radiol; 2008 Jan; 65(1):133-9. PubMed ID: 17485189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concepts of myocardial perfusion imaging in magnetic resonance imaging.
    Wilke N; Jerosch-Herold M; Stillman AE; Kroll K; Tsekos N; Merkle H; Parrish T; Hu X; Wang Y; Bassingthwaighte J
    Magn Reson Q; 1994 Dec; 10(4):249-86. PubMed ID: 7873354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conspicuity of liver hemangiomas: short tau inversion recovery, T1, and T2 imaging with gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid.
    Brody JM; Schafer L; Tung GA; Breuer J; Shamsi K
    J Magn Reson Imaging; 2005 Apr; 21(4):391-7. PubMed ID: 15778951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accumulation of MRI contrast agents in malignant fibrous histiocytoma for gadolinium neutron capture therapy.
    Fujimoto T; Ichikawa H; Akisue T; Fujita I; Kishimoto K; Hara H; Imabori M; Kawamitsu H; Sharma P; Brown SC; Moudgil BM; Fujii M; Yamamoto T; Kurosaka M; Fukumori Y
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S355-8. PubMed ID: 19386506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging of inflammation in the peripheral and central nervous system by magnetic resonance imaging.
    Stoll G; Bendszus M
    Neuroscience; 2009 Feb; 158(3):1151-60. PubMed ID: 18651996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rat model of reperfused partial liver infarction: characterization with multiparametric magnetic resonance imaging, microangiography, and histomorphology.
    Wu X; Wang H; Chen F; Jin L; Li J; Feng Y; DeKeyzer F; Yu J; Marchal G; Ni Y
    Acta Radiol; 2009 Apr; 50(3):276-87. PubMed ID: 19160078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.